The consistent changes in the expression of Bax and BCL2 revealed that the Bax/BCL2 signaling pathway might be a common mechanism to inhibit tumor growth, which is a viable direction for creating methods for treating various malignancies. This evidence concerns the gene BAX and neoplasm.